Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis
© 2022. The Author(s)..
Overproduction of reactive oxygen species (ROS) and aberrant lipid metabolism are established hallmarks of cancer; however, the role of ROS in lipid synthesis during tumorigenesis is almost unknown. Herein, we show that ROS regulates lipid synthesis and thus controls colorectal tumorigenesis through a p53-dependent mechanism. In p53 wild-type colorectal cancer (CRC) cells, hydrogen peroxide (H2O2)-induced p53 expression represses the transcription of deubiquitinase USP22, which otherwise deubiquitinates and stabilizes Fatty Acid Synthase (FASN), and thus inhibits fatty acid synthesis. Whereas, in p53-deficient CRC cells, ROS-mediated inhibition of USP22 is relieved, leading to FASN stabilization, which thus promotes lipid synthesis and tumor growth. In human CRC specimens, USP22 expression is positively correlated with FASN expression. Our study demonstrates that ROS critically regulates lipid synthesis and tumorigenesis through the USP22-FASN axis in a p53-dependent manner, and targeting the USP22-FASN axis may represent a potential strategy for the treatment of colorectal cancer.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Cell death discovery - 8(2022), 1 vom: 04. Nov., Seite 445 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Han, Zelong [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 08.11.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1038/s41420-022-01241-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM348471629 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM348471629 | ||
| 003 | DE-627 | ||
| 005 | 20231226040313.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41420-022-01241-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1161.xml |
| 035 | |a (DE-627)NLM348471629 | ||
| 035 | |a (NLM)36333288 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Han, Zelong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 08.11.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022. The Author(s). | ||
| 520 | |a Overproduction of reactive oxygen species (ROS) and aberrant lipid metabolism are established hallmarks of cancer; however, the role of ROS in lipid synthesis during tumorigenesis is almost unknown. Herein, we show that ROS regulates lipid synthesis and thus controls colorectal tumorigenesis through a p53-dependent mechanism. In p53 wild-type colorectal cancer (CRC) cells, hydrogen peroxide (H2O2)-induced p53 expression represses the transcription of deubiquitinase USP22, which otherwise deubiquitinates and stabilizes Fatty Acid Synthase (FASN), and thus inhibits fatty acid synthesis. Whereas, in p53-deficient CRC cells, ROS-mediated inhibition of USP22 is relieved, leading to FASN stabilization, which thus promotes lipid synthesis and tumor growth. In human CRC specimens, USP22 expression is positively correlated with FASN expression. Our study demonstrates that ROS critically regulates lipid synthesis and tumorigenesis through the USP22-FASN axis in a p53-dependent manner, and targeting the USP22-FASN axis may represent a potential strategy for the treatment of colorectal cancer | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Liu, Ming |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Yuxin |e verfasserin |4 aut | |
| 700 | 1 | |a Zeng, Kunlin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhan, Ziling |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Yanwen |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Li |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Xiaoxia |e verfasserin |4 aut | |
| 700 | 1 | |a Luo, Yaxin |e verfasserin |4 aut | |
| 700 | 1 | |a Zeng, Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Zhan, Hongchao |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Yingzhuo |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Keqin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Xiaoxia |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Side |e verfasserin |4 aut | |
| 700 | 1 | |a Luo, Xiaobei |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Aidong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell death discovery |d 2015 |g 8(2022), 1 vom: 04. Nov., Seite 445 |w (DE-627)NLM251897435 |x 2058-7716 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2022 |g number:1 |g day:04 |g month:11 |g pages:445 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41420-022-01241-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2022 |e 1 |b 04 |c 11 |h 445 | ||